• Type 2 Diabetes Management Treatment • Type 1 Diabetes: Pathophysiology • GLP-1 Receptor Agonists in Chronic Kidney Disease (CKD) • Cardiovascular-Kidney-Metabolic (CKM) Syndrome • Head-to-Head Evidence: Semaglutide vs. Tirzepatide
Annual FDA New Drug Update by expert Dr. C. Wayne Weart
Attend Live or Via Zoom for same Live Credit universitylearning.com Accredited Pharmacology CE/CME/CEU since 1979
